{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:29:02Z","timestamp":1775240942789,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ygyno.2010.04.007","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T10:37:36Z","timestamp":1273660656000},"page":"189-195","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation of EVI1 and EVI1s (\u0394324) as potential therapeutic targets in ovarian cancer"],"prefix":"10.1016","volume":"118","author":[{"given":"Amir A.","family":"Jazaeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Stuart","family":"Ferriss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Susan","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anindya","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.04.007_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2010.04.007_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1517\/14656566.8.14.2293","article-title":"Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics","volume":"8","author":"Modesitt","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ygyno.2010.04.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2005.09.020","article-title":"EVI1 and hematopoietic disorders: History and perspectives","volume":"368","author":"Nucifora","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.gene.2007.04.012","article-title":"The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions","volume":"396","author":"Wieser","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib5","first-page":"963","article-title":"Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts","volume":"5","author":"Morishita","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib6","first-page":"925","article-title":"Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs","volume":"5","author":"Bordereaux","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib7","first-page":"939","article-title":"Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells","volume":"9","author":"Bartholomew","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib8","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/sj.onc.1201732","article-title":"Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts","volume":"16","author":"Kilbey","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib9","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1038\/sj.onc.1208754","article-title":"Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP","volume":"24","author":"Nitta","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib10","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1158\/0008-5472.CAN-06-0683","article-title":"Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer","volume":"66","author":"Sunde","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.04.007_bib11","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-06-2366","article-title":"Amplification of MDS1\/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer","volume":"67","author":"Nanjundan","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2010.04.007_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/sj.onc.1209403","article-title":"Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K\/AKT","author":"Liu","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2010.04.007_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1471-2407-9-368","article-title":"Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas","volume":"9","author":"Osterberg","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2010.04.007_bib14","doi-asserted-by":"crossref","first-page":"30357","DOI":"10.1074\/jbc.M705178200","article-title":"ATR pathway is the primary pathway for activating G2\/M checkpoint induction after re-replication","volume":"282","author":"Lin","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2010.04.007_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-2-32","article-title":"BRCA1-mediated repression of select X chromosome genes 2","volume":"2","author":"Jazaeri","year":"2004","journal-title":"J Transl Med"},{"key":"10.1016\/j.ygyno.2010.04.007_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/gcc.10144","article-title":"Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1\/EVI1, in patients with myeloid leukemia","volume":"36","author":"Vinatzer","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ygyno.2010.04.007_bib17","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1091\/mbc.E06-04-0340","article-title":"Targeted comparative RNA interference analysis reveals differential requirement of genes essential for cell proliferation","volume":"17","author":"Machida","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ygyno.2010.04.007_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.04.007_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molonc.2008.05.001","article-title":"Overexpression of SnoN\/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis","volume":"2","author":"Nanjundan","year":"2008","journal-title":"Mol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810002933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810002933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T01:56:24Z","timestamp":1544493384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810002933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0090825810002933"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.04.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}